Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mitsubishi Chemical Advanced Materials is the Advanced Materials Division of Mitsubishi Chemical Group and a global manufacturer of high-performance thermoplastics, composite materials, and machined plastic solutions. The business serves multiple end markets including medical, healthcare, food and pharma, aerospace, mobility, energy, and electronics. In healthcare, it supplies medical-grade polymers, implantable biomaterials, coatings, and engineered material solutions used in devices such as catheters, guidewires, introducers, valves, orthopedic applications, and other short- and long-term implantable products. Rather than operating as a drug-development biotech, the company is a commercial materials and manufacturing-focused organization whose value proposition centers on materials science, processing, prototyping, and application engineering. Its portfolio includes semi-finished products, finished machined parts, injection molding solutions, composites, and specialty biomaterials marketed through brands such as AdvanSource and KyronMAX.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mitsubishi Chemical Advanced Materials.